Ligand · LOI

LOI · 2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide

LOI, 2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide (C15 H16 N6 O S2, 360.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…

Component: LOI
Formula: C15 H16 N6 O S2
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

LOI in 2 structures; the first of them:

3GOI · Human glucokinase in complex with a synthetic activator · LOI A1 · binds TYR61, VAL62, ARG63, SER64, PRO66, ILE159, MET210, ILE211 and 8 more
3GOI · Human glucokinase in complex with a synthetic activator · LOI A1 · binds TYR61, VAL62, ARG63, SER64, PRO66, ILE159, MET210, ILE211 and 8 more

Residues it binds most

VAL 2, ILE 2, MET 2, TYR 2, ARG 2, CYS 2, GLU 2, HIS 2, LEU 2, PRO 2 (residue and the binding sites it lines).

Found with

GLC · alpha-D-glucopyranose

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.